1
|
Pérez SE, Torre AC, Echeverría M, Cura MJ, Caviedes M, Mazzuoccolo LD. [Translated article] Heparin-Induced Bullous Hemorrhagic Dermatosis: An Underdiagnosed Reaction? Actas Dermosifiliogr 2024; 115:T409-T411. [PMID: 38325546 DOI: 10.1016/j.ad.2022.09.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Accepted: 09/20/2022] [Indexed: 02/09/2024] Open
Affiliation(s)
- S E Pérez
- Departamento de Dermatología. Hospital Italiano de Buenos Aires. Buenos Aires, Argentina.
| | - A C Torre
- Departamento de Dermatología. Hospital Italiano de Buenos Aires. Buenos Aires, Argentina
| | - M Echeverría
- Departamento de Dermatología. Hospital Italiano de Buenos Aires. Buenos Aires, Argentina
| | - M J Cura
- Departamento de Dermatología. Hospital Italiano de Buenos Aires. Buenos Aires, Argentina
| | - M Caviedes
- Departamento de Dermatología. Hospital Italiano de Buenos Aires. Buenos Aires, Argentina
| | - L D Mazzuoccolo
- Departamento de Dermatología. Hospital Italiano de Buenos Aires. Buenos Aires, Argentina
| |
Collapse
|
2
|
Pérez SE, Torre AC, Echeverría M, Cura MJ, Caviedes M, Mazzuoccolo LD. Heparin-Induced Bullous Hemorrhagic Dermatosis: An Underdiagnosed Reaction? Actas Dermosifiliogr 2024; 115:409-411. [PMID: 37088294 DOI: 10.1016/j.ad.2022.09.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Revised: 09/16/2022] [Accepted: 09/20/2022] [Indexed: 04/25/2023] Open
Affiliation(s)
- S E Pérez
- Departamento de Dermatología, Hospital Italiano de Buenos Aires. Buenos Aires, Argentina.
| | - A C Torre
- Departamento de Dermatología, Hospital Italiano de Buenos Aires. Buenos Aires, Argentina
| | - M Echeverría
- Departamento de Dermatología, Hospital Italiano de Buenos Aires. Buenos Aires, Argentina
| | - M J Cura
- Departamento de Dermatología, Hospital Italiano de Buenos Aires. Buenos Aires, Argentina
| | - M Caviedes
- Departamento de Dermatología, Hospital Italiano de Buenos Aires. Buenos Aires, Argentina
| | - L D Mazzuoccolo
- Departamento de Dermatología, Hospital Italiano de Buenos Aires. Buenos Aires, Argentina
| |
Collapse
|
3
|
Bruchanski L, Torre AC, Bibiloni N, Sommer J, Boietti B, Grande Ratti MF, Rapisarda R, Luna D, Mazzuoccolo L, Plazzotta F. Effect of the COVID-19 Lockdown on Patients Valuation of Usability of Telemedicine. Stud Health Technol Inform 2024; 310:394-398. [PMID: 38269832 DOI: 10.3233/shti230994] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2024]
Abstract
The aim of this paper was to report patient valuation of usability with our telemedicine system and to explore the effect of pandemic in its behavior. We conducted a cross-sectional study based on the prospective recollection of the results of the Spanish abbreviated version of the Telehealth Usability Questionnaire (TUQ), from October 2019 to July 2020. We observed an inflection point of growth of answers during the pandemic era and a trend of decrease in usability valuations coinciding with the massive and forced implementation of the system after lockdown. This effect was transitory, evidencing an improvement over time. These results might be explained with a sociotechnical approach that includes considering the learning curve and suggest the importance of a telemedicine usability tool to guide decision-making. In conclusion, tools to assess telemedicine services may identify facilitators and barriers to its use in a highly changing social and technological context.
Collapse
Affiliation(s)
- Lucila Bruchanski
- Department of Health Informatics, Hospital Italiano de Buenos Aires, Argentina
| | - Ana Clara Torre
- Department of Dermatology, Hospital Italiano de Buenos Aires, Argentina
| | - Nuria Bibiloni
- Department of Dermatology, Hospital Italiano de Buenos Aires, Argentina
| | - Janine Sommer
- Department of Health Informatics, Hospital Italiano de Buenos Aires, Argentina
| | - Bruno Boietti
- University of Hospital Italiano de Buenos Aires, Argentina
| | | | - Romina Rapisarda
- Department of Health Informatics, Hospital Italiano de Buenos Aires, Argentina
| | - Daniel Luna
- Department of Health Informatics, Hospital Italiano de Buenos Aires, Argentina
| | - Luis Mazzuoccolo
- Department of Dermatology, Hospital Italiano de Buenos Aires, Argentina
| | - Fernando Plazzotta
- Department of Health Informatics, Hospital Italiano de Buenos Aires, Argentina
| |
Collapse
|
4
|
di Prinzio A, Torre AC, Mazzuoccolo LD. [Translated article] Acquired Epidermodysplasia Verruciformis in a Solid Organ Transplant Recipient. Actas Dermosifiliogr 2023; 114:T911. [PMID: 37734547 DOI: 10.1016/j.ad.2023.09.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2022] [Revised: 11/14/2022] [Accepted: 11/29/2022] [Indexed: 09/23/2023] Open
Affiliation(s)
- A di Prinzio
- Servicio de Dermatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
| | - A C Torre
- Servicio de Dermatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - L D Mazzuoccolo
- Servicio de Dermatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| |
Collapse
|
5
|
di Prinzio A, Torre AC, Mazzuoccolo LD. Acquired Epidermodysplasia Verruciformis in a Solid Organ Transplant Recipient. Actas Dermosifiliogr 2023; 114:911. [PMID: 37088290 DOI: 10.1016/j.ad.2022.11.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2022] [Revised: 11/14/2022] [Accepted: 11/29/2022] [Indexed: 04/25/2023] Open
Affiliation(s)
- A di Prinzio
- Servicio de Dermatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
| | - A C Torre
- Servicio de Dermatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - L D Mazzuoccolo
- Servicio de Dermatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| |
Collapse
|
6
|
Sommer J, Torre AC, Bibiloni N, Plazzotta F, Vázquez Peña F, Terrasa SA, Boietti B, Bruchanski L, Mazzuoccolo L, Luna D. Telemedicina: validación de un cuestionario para evaluar la experiencia de los profesionales de la salud. Rev Panam Salud Publica 2022; 46:e173. [PMID: 36320203 PMCID: PMC9595219 DOI: 10.26633/rpsp.2022.173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2022] [Accepted: 05/23/2022] [Indexed: 11/24/2022] Open
Abstract
Objetivo. El siguiente trabajo tiene como objetivo desarrollar y validar un cuestionario para evaluar la experiencia de los profesionales de la salud con los sistemas de telemedicina. Métodos. A partir de la versión abreviada en español y validada localmente del cuestionario para pacientes desarrollado por Parmanto y col., un grupo de expertos consensuó una versión para evaluar la experiencia de profesionales de la salud que brindan servicios de telemedicina. El comportamiento psicométrico de los ítems se testeó en una primera muestra de 129 profesionales a través de un análisis factorial exploratorio. Luego, se evaluó su comprensibilidad a través de entrevistas cognitivas. Por último, en una nueva muestra de 329 profesionales, se evaluó la validez de constructo del cuestionario mediante un análisis factorial confirmatorio (AFC), y su validez de criterio externo, mediante la evaluación de su puntaje con el de una pregunta de resumen. Resultados. Se obtuvo un cuestionario de 12 ítems con una estructura de dos factores con indicadores de ajuste aceptables, documentada mediante AFC. La fiabilidad, la validez convergente y la validez discriminante fueron apropiadas. La validez de criterio externo mostró resultados óptimos. Conclusiones. El instrumento obtenido cuenta con propiedades psicométricas adecuadas y contribuirá a la evaluación objetiva de la experiencia de los profesionales que realizan telemedicina.
Collapse
Affiliation(s)
- Janine Sommer
- Departamento de Informática en salud, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
| | - Ana Clara Torre
- Servicio de Dermatología, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
| | - Nuria Bibiloni
- Servicio de Dermatología, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
| | - Fernando Plazzotta
- Departamento de Informática en salud, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
| | - Fernando Vázquez Peña
- Departamento de Investigación, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
| | - Sergio Adrián Terrasa
- Departamento de Investigación, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
| | - Bruno Boietti
- Departamento de Investigación, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
| | - Lucila Bruchanski
- Departamento de Informática en salud, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
| | - Luis Mazzuoccolo
- Servicio de Dermatología, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
| | - Daniel Luna
- Departamento de Informática en salud, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
| |
Collapse
|
7
|
Ingen-Housz-Oro S, Milpied B, Badrignans M, Carrera C, Elshot YS, Bensaid B, Segura S, Apalla Z, Markova A, Staumont-Sallé D, Marti-Marti I, Giavedoni P, Chua SL, Darrigade AS, Dezoteux F, Starace M, Torre AC, Riganti J, de Prost N, Lebrun-Vignes B, Bauvin O, Walsh S, Ortonne N, French LE, Sibaud V. Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases. Melanoma Res 2022; 32:205-210. [PMID: 35377864 PMCID: PMC9377568 DOI: 10.1097/cmr.0000000000000819] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
Among dermatologic adverse events induced by immune checkpoint inhibitors (ICI), bullous life-threatening reactions are rare. To better define the clinical and histological features, treatment, and prognosis of ICI-related severe blistering cutaneous eruptions. This retrospective case series was conducted between 2014/05/15 and 2021/04/15 by the dermatology departments of four international registries involved in drug reactions. Inclusion criteria were age ≥18 years old, skin eruption with blisters with detachment covering ≥1% body surface area and at least one mucous membrane involved, available pictures, and ICI as suspect drug. Autoimmune bullous disorders were excluded. Each participant medical team gave his own diagnosis conclusion: epidermal necrolysis (EN), severe lichenoid dermatosis (LD), or unclassified dermatosis (UD). After a standardized review of pictures, cases were reclassified by four experts in EN or LD/UD. Skin biopsies were blindly reviewed. Thirty-two patients were included. Median time to onset was 52 days (3-420 days). Cases were originally diagnosed as EN in 21 cases and LD/UD in 11 cases. After review by experts, 10/21 EN were reclassified as LD/UD. The following manifestations were more frequent or severe in EN: fever, purpuric macules, blisters, ocular involvement, and maximal detachment. Most patients were treated with topical with or without systemic corticosteroids. Eight patients (25%) died in the acute phase. The culprit ICI was not resumed in 92% of cases. In three patients, another ICI was given with a good tolerance. Histology did not reveal significant differences between groups. Severe blistering cutaneous drug reactions induced by ICI are often overdiagnosed as EN. Consensus for management is pending.
Collapse
Affiliation(s)
- Saskia Ingen-Housz-Oro
- Dermatology department, AP-HP, Henri Mondor hospital, Créteil, France
- Reference center for toxic bullous diseases and severe drug reactions TOXIBUL, Créteil, France
- FISARD group, Paris, France
- Univ Paris est Créteil EpidermE, Créteil, France
- European Task Force “Dermatology for cancer patients” of EADV
- ToxiTEN group, European Reference Network for Rare Skin Diseases, Paris, France
| | - Brigitte Milpied
- Reference center for toxic bullous diseases and severe drug reactions TOXIBUL, Créteil, France
- FISARD group, Paris, France
- European Task Force “Dermatology for cancer patients” of EADV
- ToxiTEN group, European Reference Network for Rare Skin Diseases, Paris, France
- Dermatology department, CHU Bordeaux, Bordeaux, France
| | - Marine Badrignans
- Pathology department, AP-HP, Henri Mondor hospital, Créteil, France
- Université Paris Est Créteil Val de Marne UPEC, Créteil, France
| | - Cristina Carrera
- European Task Force “Dermatology for cancer patients” of EADV
- Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain
- CIBERER Centro de investigaciones Biomedicas en Red de Enfermedades Raras Insituto de Salud Carlos III, Spain
- Pharmacovigilance Technical Committee Hospital Clinic Barcelona, Spain
| | - Yannick S. Elshot
- European Task Force “Dermatology for cancer patients” of EADV
- Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands
- Department of Dermatology, Amsterdam UMC, Univ. of Amsterdam, The Netherlands
| | - Benoit Bensaid
- Reference center for toxic bullous diseases and severe drug reactions TOXIBUL, Créteil, France
- FISARD group, Paris, France
- Dermatology department, CHU Edouard Herriot, Lyon, France
| | - Sonia Segura
- European Task Force “Dermatology for cancer patients” of EADV
- Dermatology Department, Hospital del Mar, Universitat Pompeu Fabra, Barcelona, Spain
| | - Zoé Apalla
- European Task Force “Dermatology for cancer patients” of EADV
- Second Dermatology Department, Medical School, Aristotle University of Thessaloniki, Greece
| | - Alina Markova
- European Task Force “Dermatology for cancer patients” of EADV
- Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Dermatology, Weill Cornell Medical College, New York, NY, USA
| | - Delphine Staumont-Sallé
- FISARD group, Paris, France
- Dermatology Department, CHU Lille, University Lille, INFINITE U1286 Inserm, Lille, France
| | - Ignasi Marti-Marti
- European Task Force “Dermatology for cancer patients” of EADV
- Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain
| | - Priscila Giavedoni
- European Task Force “Dermatology for cancer patients” of EADV
- Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain
| | - Ser-Ling Chua
- ToxiTEN group, European Reference Network for Rare Skin Diseases, Paris, France
- Department of Dermatology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
| | - Anne-Sophie Darrigade
- Reference center for toxic bullous diseases and severe drug reactions TOXIBUL, Créteil, France
- FISARD group, Paris, France
- Dermatology department, CHU Bordeaux, Bordeaux, France
| | - Frédéric Dezoteux
- FISARD group, Paris, France
- Dermatology Department, CHU Lille, University Lille, INFINITE U1286 Inserm, Lille, France
| | - Michela Starace
- European Task Force “Dermatology for cancer patients” of EADV
- Dermatology -IRCCS Policlinico di Sant’Orsola - Department of Experimental, Diagnostic and Specialty Medicine (DIMES) Alma Mater Studiorum University of Bologna, Italy
| | - Ana Clara Torre
- European Task Force “Dermatology for cancer patients” of EADV
- Dermatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Julia Riganti
- European Task Force “Dermatology for cancer patients” of EADV
- Dermatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Nicolas de Prost
- Reference center for toxic bullous diseases and severe drug reactions TOXIBUL, Créteil, France
- Intensive care unit, AP-HP, Henri Mondor hospital, Créteil, France
| | - Bénédicte Lebrun-Vignes
- Reference center for toxic bullous diseases and severe drug reactions TOXIBUL, Créteil, France
- FISARD group, Paris, France
- ToxiTEN group, European Reference Network for Rare Skin Diseases, Paris, France
- Regional Pharmacovigilance Center, AP-HP, Pitié-Salpêtrière hospital, Paris, France
| | - Olivia Bauvin
- FISARD group, Paris, France
- Dermatology department, CHU Charles Nicolle, Rouen, France
| | - Sarah Walsh
- ToxiTEN group, European Reference Network for Rare Skin Diseases, Paris, France
- Department of Dermatology, King’s College Hospital, London, United Kingdom
| | - Nicolas Ortonne
- Reference center for toxic bullous diseases and severe drug reactions TOXIBUL, Créteil, France
- Pathology department, AP-HP, Henri Mondor hospital, Créteil, France
- Université Paris Est Créteil Val de Marne UPEC, Créteil, France
| | - Lars E. French
- ToxiTEN group, European Reference Network for Rare Skin Diseases, Paris, France
- Department of Dermatology and Allergy, University Hospital, Ludwig Maximilan University (LMU) Munich, Munich, Germany
- Dr. Philip Frost, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL
| | - Vincent Sibaud
- European Task Force “Dermatology for cancer patients” of EADV
- Department of Oncodermatology, Claudius Regaud Institute and University Cancer Institute Toulouse Oncopole, Toulouse, France
| |
Collapse
|
8
|
Di Prinzio A, Bastard DP, Torre AC, Mazzuoccolo LD. Hand, foot, and mouth disease in adults caused by Coxsackievirus B1-B6. An Bras Dermatol 2022; 97:321-325. [PMID: 35272920 PMCID: PMC9133263 DOI: 10.1016/j.abd.2021.03.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2020] [Revised: 03/05/2021] [Accepted: 03/15/2021] [Indexed: 11/19/2022] Open
Abstract
Hand, foot, and mouth disease is a viral rickettsial disease caused by Coxsackievirus A16 and Enterovirus 71 in most cases. It is commonly seen in children under ten years old, who present oral enanthema and a macular, maculopapular, or vesicular rash on their hands and feet. However, an increase in cases caused by other viral serotypes was observed in adults in recent years with various clinical presentations and a troublesome diagnosis. Three cases of hand, foot, and mouth disease are reported to show the clinical variability and diagnostic complexity that this disease may present in adult patients.
Collapse
Affiliation(s)
- Anama Di Prinzio
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Dolores Pilar Bastard
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Ana Clara Torre
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
| | | |
Collapse
|
9
|
Angles MV, Antonietti CA, Torre AC, Juszkiewicz Franzé E, Mazzuoccolo LD, Parisi CAS. Prevalence of atopic dermatitis in adults. An Bras Dermatol 2021; 97:107-109. [PMID: 34839985 PMCID: PMC8799860 DOI: 10.1016/j.abd.2020.10.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2020] [Revised: 09/29/2020] [Accepted: 10/26/2020] [Indexed: 11/24/2022] Open
Affiliation(s)
- Maria Valeria Angles
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
| | | | - Ana Clara Torre
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | | | | | | |
Collapse
|
10
|
Ferraresso MG, Bollea-Garlatti ML, Torre AC, Comparatore M, Nucifora E, Aguirre MA, Mazzuoccolo LD. Systemic amyloidosis: The skin as a clue of an unexpected diagnosis. Int J Womens Dermatol 2021; 7:359-360. [PMID: 34222600 PMCID: PMC8243144 DOI: 10.1016/j.ijwd.2020.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 11/17/2020] [Accepted: 12/01/2020] [Indexed: 11/19/2022] Open
Affiliation(s)
| | | | - Ana Clara Torre
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Mariela Comparatore
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Elsa Nucifora
- Haematology Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - María Adela Aguirre
- Department of Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | | |
Collapse
|
11
|
Distel C, Bollea Garlatti ML, Torre AC, Riganti J. Acute generalized exanthematous pustulosis with features mimicking toxic epidermal necrolysis secondary to amiodarone. An Bras Dermatol 2020; 95:540-542. [PMID: 32522449 PMCID: PMC7335889 DOI: 10.1016/j.abd.2019.11.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2019] [Accepted: 11/30/2019] [Indexed: 12/27/2022] Open
Affiliation(s)
- Cheryl Distel
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
| | | | - Ana Clara Torre
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Julia Riganti
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| |
Collapse
|
12
|
Ferraresso MG, Torre AC, Piva MMM, Barcan L. Chagas disease reactivation: cutaneous manifestations in a transplanted patient. An Bras Dermatol 2019; 93:890-892. [PMID: 30484538 PMCID: PMC6256210 DOI: 10.1590/abd1806-4841.20187855] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2017] [Accepted: 01/18/2018] [Indexed: 10/27/2022] Open
Abstract
Chagas disease is an endemic zoonosis caused by a protozoan agent called Trypanosoma cruzi. It is mainly transmitted by a hematophagous vector, and less frequently by blood transfusion, transplacental and solid organ transplant. In most cases, primary infection is not diagnosed and the disease progresses to a chronic phase. Immunosuppressed patients are a vulnerable population that may present an acute, atypical and severe reactivation of the chronic form of this disease. We hereby report a case of a female patient, who received a renal transplant with immunosuppressive treatment, who was diagnosed with a chagasic hypodermitis secondary to an acute reactivation of a chronic phase of this disease. We describe the clinical features, epidemiological and histopathological findings, treatment and course.
Collapse
Affiliation(s)
| | - Ana Clara Torre
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos
Aires, Argentina
| | | | - Laura Barcan
- Infectology section, Department of Internal Medicine, Hospital
Italiano de Buenos Aires, Buenos Aires, Argentina
| |
Collapse
|
13
|
Cura MJ, Torre AC, Cueto Sarmiento KY, Bollea Garlatti ML, Riganti J, Barcan L, Blanco JB, Mazzuoccolo LD. Reticular rash in drug reaction with eosinophilia and systemic symptoms syndrome: A clue to parvovirus B19 reactivation? JAAD Case Rep 2018; 4:728-732. [PMID: 30167447 PMCID: PMC6113673 DOI: 10.1016/j.jdcr.2018.03.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
14
|
Vacas AS, Bollea-Garlatti ML, Torre AC, Galimberti RL. Bullous pyoderma gangrenosum as a predictor of hematological malignancies. An Bras Dermatol 2018; 93:133-134. [PMID: 29641716 PMCID: PMC5871381 DOI: 10.1590/abd1806-4841.20187031] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2017] [Accepted: 03/30/2017] [Indexed: 11/21/2022] Open
Abstract
Pyoderma gangrenosum may precede, coexist or follow diverse systemic diseases. The bullous variety is usually associated with hematologic disorders. From 31 patients with pyoderma gangrenosum diagnosed in our hospital during 10 years, only 2 presented with the bullous type. One patient had previous diagnosis of chronic myeloid leukemia. Both had fast-progressive, painful lesions, and both showed an excellent response to systemic corticosteroids. In less than 3 months the lesions recurred simultaneously with the progression of chronic myeloid leukemia in one patient and with the initial diagnosis of acute myeloid leukemia in the other one. They died in less than four weeks. These findings emphasize the importance of its timely diagnosis. Cutaneous lesions could be the first predictor of an underlying disease.
Collapse
Affiliation(s)
- Aldana Soledad Vacas
- Department of Dermatology at Hospital Italiano
de Buenos Aires - Buenos Aires, Argentina
| | | | - Ana Clara Torre
- Department of Dermatology at Hospital Italiano
de Buenos Aires - Buenos Aires, Argentina
| | | |
Collapse
|
15
|
Vacas AS, Gomez-Santana LV, Torre AC, Galimberti RL. Reactivation of Chagas-Mazza disease during treatment with infliximab. An Bras Dermatol 2017; 92:899-900. [PMID: 29364464 PMCID: PMC5786422 DOI: 10.1590/abd1806-4841.20177346] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2017] [Accepted: 07/23/2017] [Indexed: 11/21/2022] Open
Affiliation(s)
- Aldana Soledad Vacas
- Department of dermatology, Hospital Italiano de Buenos Aires - Ciudad Autónoma de Buenos Aires, Argentina
| | | | - Ana Clara Torre
- Department of dermatology, Hospital Italiano de Buenos Aires - Ciudad Autónoma de Buenos Aires, Argentina
| | - Ricardo Luis Galimberti
- Department of dermatology, Hospital Italiano de Buenos Aires - Ciudad Autónoma de Buenos Aires, Argentina
| |
Collapse
|
16
|
Bollea-Garlatti ML, Bollea-Garlatti LA, Vacas AS, Torre AC, Kowalczuk AM, Galimberti RL, Ferreyro BL. Clinical Characteristics and Outcomes in a Population With Disseminated Herpes Zoster: A Retrospective Cohort Study. Actas Dermosifiliogr 2016; 108:145-152. [PMID: 27938930 DOI: 10.1016/j.ad.2016.10.009] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2016] [Revised: 09/07/2016] [Accepted: 10/09/2016] [Indexed: 11/16/2022] Open
Abstract
INTRODUCTION Shingles is the cutaneous expression of the reactivation of latent varicella zoster virus infection in sensory ganglia. It presents as vesicles in the corresponding dermatome. The condition is called disseminated herpes zoster (DHZ) when more than 2 contiguous dermatomes are affected, more than 20 vesicles are observed outside the initial dermatome, or involvement is systemic. DHZ is rare and most frequently occurs in immunocompromised patients. OBJECTIVES To describe the epidemiology, predisposing factors, clinical presentation, laboratory findings, and clinical course of patients with DHZ, and to compare the findings in immunocompromised and immunocompetent patients. METHODOLOGY We analyzed a retrospective case series of adults hospitalized between February 2010 and October 2015. RESULTS Forty-one patients with virologically confirmed manifestations of DHZ were included. Stress as a trigger factor was detected in 39% and immunodepression in 58.5%. Immunocompromised patients were younger than the immunocompetent patients (mean ages, 60.5 vs 82 years, P<.01). The 8 immunocompetent patients with no detectable trigger factors were older (mean age, 85 years). In 95% of cases, DHZ was initially limited to a single dermatome and then spread to other dermatomes or became disseminated. Thrombocytopenia was detected in 56% of cases. Complication rates were similar in immunocompromised and immunocompetent patients (54% vs 59%, P>.01). Six patients died; there was no difference in mortality between the 2 groups. CONCLUSION This study provides evidence on the relationship between DHZ, the presence of underlying immunodepression, and complications. Immunosenescence may play an important role in the onset of this disease in older immunocompetent patients.
Collapse
Affiliation(s)
- M L Bollea-Garlatti
- Departamento de Dermatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
| | - L A Bollea-Garlatti
- Departamento de Dermatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - A S Vacas
- Departamento de Dermatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - A C Torre
- Departamento de Dermatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - A M Kowalczuk
- Departamento de Dermatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - R L Galimberti
- Departamento de Dermatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Cátedra de Dermatología, Universidad de Buenos Aires, Buenos Aires, Argentina
| | - B L Ferreyro
- Departamento de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Cátedra de Farmacología, Universidad de Buenos Aires, Buenos Aires, Argentina
| |
Collapse
|
17
|
Key Words
- Autoinflammatory
- IL, interleukin
- PAPA, pyogenic arthritis, pyoderma gangrenosum, and acne
- PASH, pyoderma gangrenosum, acne, and suppurative hidradenitis
- PG, pyoderma gangrenosum
- TNF, tumor necrosis factor
- UC, ulcerative colitis
- canakinumab
- interleukin-1β
- pyoderma gangrenosum
Collapse
Affiliation(s)
| | - Aldana Soledad Vacas
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | | | - Ana Clara Torre
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| |
Collapse
|
18
|
Bollea Garlatti LA, Torre AC, Bollea Garlatti ML, Galimberti RL, Argenziano G. Dermoscopy aids the diagnosis of crusted scabies in an erythrodermic patient. J Am Acad Dermatol 2015; 73:e93-5. [PMID: 26282822 DOI: 10.1016/j.jaad.2015.04.061] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2015] [Revised: 04/29/2015] [Accepted: 04/30/2015] [Indexed: 10/23/2022]
Affiliation(s)
| | - Ana Clara Torre
- Department of Dermatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | | | | | - Giuseppe Argenziano
- Skin Cancer Unit, Arcispedale Santa Maria Nuova Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Reggio Emilia, Italy
| |
Collapse
|
19
|
Abstract
Systemic mycoses are a heterogeneous group of infections caused by different species of fungi that mainly affect individuals with primary or secondary alterations of immunity. In recent years, there has been an increase in the incidence of infections related to migration, AIDS, and other causes of immunosuppression, such as solid organ and bone marrow transplantation; oncological, hematological, and autoimmune diseases; and the use of new drugs. In this paper, we outline the microbiological and epidemiological characteristics of 3 fungi: Aspergillus spp, Fusarium spp, and Penicillium spp. We describe the clinical manifestations of disease with emphasis on those that should alert the dermatologist to make an early diagnosis. We detail the various tools for early diagnosis, prevention, and the epidemiology of different antifungals available for treatment and their mechanism of action and therapeutic efficacy.
Collapse
Affiliation(s)
- Ricardo Galimberti
- Department of Dermatology, Hospital Italiano de Buenos Aires, Juan D. Peron 4190 (CP1181ACH), Buenos Aires, Argentina.
| | | | | | | |
Collapse
|